Literature DB >> 18188743

Craving, withdrawal, and smoking urges on days immediately prior to smoking relapse.

Sharon S Allen1, Tracy Bade, Dorothy Hatsukami, Bruce Center.   

Abstract

Rates of smoking relapse remain high, despite the wide availability of cessation aids. Presumably factors such as craving, withdrawal symptoms, and smoking urges are key contributors to relapse, but empirical support for this presumption is not conclusive and is complicated by the high variability in symptoms across individuals and time, as well as by the lack of an absolute symptom threshold for response. Data were analyzed from 137 female smokers, aged 18-40 years, who completed 30 days of a protocol for a longitudinal smoking cessation trial. Subjects were assigned a quit date and followed regardless of subsequent smoking status. At baseline, subjects completed written measures of nicotine craving, withdrawal symptoms, and smoking urges. They also completed these measures daily for 30 days, beginning on their quit date, Scores were standardized within subjects and graphed to identify temporal symptom patterns. A total of 26 women quit smoking and 111 relapsed (at least one cigarette puff). The intensity of subjects' craving, withdrawal, and smoking urges Factors 1 and 2 peaked on the day of relapse by an average of 1.4, 1.1, 1.2, and 1.1 standard deviations, respectively, with symptoms rising during the previous 2-5 days and dropping precipitously over the 2 days subsequent to relapse. Additionally, women who relapsed had higher absolute (unstandardized) symptom scores on their quit day than those who were abstinent for 30 days. These findings imply that escalation of withdrawal symptoms, craving, and smoking urges during a quit attempt may contribute to smoking relapse. Frequent symptom monitoring might be clinically important for relapse prevention.

Entities:  

Mesh:

Year:  2008        PMID: 18188743     DOI: 10.1080/14622200701705076

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  71 in total

1.  Mindful attention reduces neural and self-reported cue-induced craving in smokers.

Authors:  Cecilia Westbrook; John David Creswell; Golnaz Tabibnia; Erica Julson; Hedy Kober; Hilary A Tindle
Journal:  Soc Cogn Affect Neurosci       Date:  2011-11-22       Impact factor: 3.436

2.  Temporal and probability discounting by cigarette smokers following acute smoking abstinence.

Authors:  Richard Yi; Reid D Landes
Journal:  Nicotine Tob Res       Date:  2012-02-06       Impact factor: 4.244

3.  Postquitting experiences and expectations of adult smokers and their association with subsequent relapse: findings from the International Tobacco Control (ITC) Four Country Survey.

Authors:  Hua-Hie Yong; Ron Borland; Jae Cooper; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2010-10       Impact factor: 4.244

4.  Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India.

Authors:  Sonali Jhanjee; Raka Jain; Veena Jain; Tina Gupta; Swati Mittal; Patricia Goelz; Robert A Schnoll
Journal:  J Psychoactive Drugs       Date:  2015-08-28

5.  Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Authors:  John A Dani; Mariella De Biasi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

6.  Differential prevalence of established risk factors for poor cessation outcomes among smokers by level of social anxiety.

Authors:  Noreen L Watson; Jaimee L Heffner; Jennifer B McClure; Kristen E Mull; Jonathan B Bricker
Journal:  Am J Addict       Date:  2017-02-13

7.  Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.

Authors:  Lisa R LaRowe; Jesse D Kosiba; Emily L Zale; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

8.  Right anterior insula connectivity is important for cue-induced craving in nicotine-dependent smokers.

Authors:  Megan M Moran-Santa Maria; Karen J Hartwell; Colleen A Hanlon; Melanie Canterberry; Todd Lematty; Max Owens; Kathleen T Brady; Mark S George
Journal:  Addict Biol       Date:  2014-02-13       Impact factor: 4.280

9.  Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial.

Authors:  Nicole L Tosun; Ann M Fieberg; Lynn E Eberly; Katherine A Harrison; Angela R Tipp; Alicia M Allen; Sharon S Allen
Journal:  Addiction       Date:  2019-06-17       Impact factor: 6.526

10.  Scientific overview: 2013 BBC plenary symposium on tobacco addiction.

Authors:  M De Biasi; I McLaughlin; E E Perez; P A Crooks; L P Dwoskin; M T Bardo; P R Pentel; D Hatsukami
Journal:  Drug Alcohol Depend       Date:  2014-06-02       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.